DP3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Central Pharmaceutical JSC No3

Watchlist Manager

Watchlist

Price: 62 100 VND 0.16% Market Closed

Market Cap: ₫1.3T

C	Central Pharmaceutical JSC No3 VN:DP3	VN
F	First Majestic Silver Corp NYSE:AG	CA
B	Briscoe Group Ltd ASX:BGP	NZ
E	Energy of Minas Gerais Co BOVESPA:CMIG3	BR
I	Itochu Corp F:IOC	JP
	Henkel AG & Co KGaA XETRA:HEN3	DE
R	RWE AG XHAM:RWE	DE
	Vodacom Group Ltd OTC:VODAF	ZA
	Kofola CeskoSlovensko as LSE:0RD3	CZ
B	Billionbrains Garage Ventures Ltd NSE:GROWW	IN
T	thyssenkrupp AG XBER:TKA1	DE
	Benjamin Hill Mining Corp OTC:FRGGF	CA
S	Sana Biotechnology Inc NASDAQ:SANA	US
T	Tyman PLC XBER:LUO1	UK
I	IG Group Holdings PLC OTC:IGGHY	UK

Profitability Summary

Central Pharmaceutical JSC No3's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

66%

Strong 3Y Average Gross Margin

67%

Declining Gross Margin

69% > 66%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

26% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

30%

Net Margin is Increasing

21% > 35%

Exceptional Free Cash Flow Margin

55%

Strong 3Y Average Free Cash Flow Margin

32%

Free Cash Flow Margin is Increasing

15% > 55%

Exceptional ROE

27%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

41%

ROIC is Increasing

44% > 52%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.